As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound , he’s barely mentioned Medicare’s drug price negotiation program — even though the government is expected to announce lower prices before the end of the month.

The program, created under President Joe Biden’s Inflation Reduction Act of 2022 , gave Medicare the authority to negotiate directly with drugmakers on some of the costliest medications.

A Centers for Medicare and Medicaid Services (CMS) spokesperson said the agency is preparing to release the second round of negotiated prices by Nov. 30 — covering 15 drugs, up from 10 last year, and adding Ozempic and Wegovy to the list. The newly negotiated prices won’t take effect until 2027.

Trump announces deal to lower cost of weig

See Full Page